Esophageal Cancer Clinical Trial

TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett’s Esophagus)

Summary

A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).

View Full Description

Full Description

Patients will be enrolled in this study at the participating centers when evaluated in gastro-intestinal (GI) clinics and endoscopy suites. Initial evaluation of patients will include collection of data on demographics, assessment of risk factors such as smoking, metabolic syndrome, family history and detailed medication history, and past surgical history. All patients will be complete questionnaires regarding Gastroesophageal Reflux Disease (GERD) symptoms, GERD related quality of life (QOL) and overall health related QOL. Details of all previous endoscopic and surgical evaluation along with histopathology data will be documented. Patients undergoing endoscopic evaluation at the participating centers will have their endoscopic and histopathology results documented. This will include data collection regarding use of advanced imaging techniques, details regarding tissue acquisition, EET and adverse events. Patients undergoing esophagectomy will have surgical details documented along with complications related to surgery. Similarly, details regarding chemoradiation treatments will be documented .

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with Barrett's related neoplasia and dysplasia. Patients with esophageal cancer

Exclusion Criteria:

Patients with squamous cell carcinoma

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

5000

Study ID:

NCT02634645

Recruitment Status:

Recruiting

Sponsor:

University of Colorado, Denver

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

UCLA Medical Center
Los Angeles California, 90095, United States More Info
V. Raman Muthusamy, MD
Contact
310-825-1892
[email protected]
V. Raman Muthusamy, MD
Principal Investigator
Moffitt Cancer Center
Tampa Florida, 33612, United States More Info
Cynthia Harris, MD
Contact
813-745-8361
[email protected]
Cynthia Harris, MD
Principal Investigator
Jason Klapman, MD
Sub-Investigator
Northwestern Memorial Hospital
Chicago Illinois, 60611, United States More Info
Srinadh Komanduri, MD
Contact
312-695-0484
[email protected]
Srinadh Komanduri, MD
Principal Investigator
Washington University
Saint Louis Missouri, 63130, United States More Info
Dayna Early, MD
Contact
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

5000

Study ID:

NCT02634645

Recruitment Status:

Recruiting

Sponsor:


University of Colorado, Denver

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.